AccueilInfos pratiques & communicationsEvènements & ColloquesWebinar: From discovery to the pre-clinical antimicrobial candidate, 25 February 2021

Webinar: From discovery to the pre-clinical antimicrobial candidate, 25 February 2021

Partager l'article
Partager sur email
Partager sur twitter
Partager sur linkedin
Crédit : Pixabay

Live webinar organized by the  Global Antibiotic Research and Development Partnership, GARDP, that will be broadcast on 25 February 2021 at 17:00-18:30 CET. Find your time zone here.

Speakers:

  • Patricia Bradford, Antimicrobial Development Specialists LLC (US)
  • Alita Miller, Entasis Therapeutics (US)

Moderator: Michael Mourez, École d’Ingénieurs de PURPAN (France)

Presentations:

Screen to pre-clinical candidate (Alita Miller):

  • Discovery strategies
  • Hit-to-lead generation
  • MOA studies
  • Spectrum of activity
  • Resistance studies
  • In vitro toxicity assessments
  • PK/PD characterization

Pre-clinical candidate to phase 1 (Patricia Bradford):

  • Non-clinical package requirements for first-in-human studies
  • Dose selection
  • Non-clinical toxicity
  • CMC considerations
  • Regulatory process/pathways

The presentations will be followed by a Q&A session.

If you have questions or comments, please let us know: revive@gardp.org.

Registration on the Global Antibiotic Research and Development website